News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
Thermo Fisher will codevelop LC-MS workflows for infectious disease detection with NanoPin and will commercialize Q-linea's antibiotic susceptibility testing platform.
While overall revenues and net income were up, analytical instruments revenues decreased 3 percent in Q4, and 2 percent organically.
Eurofins LifeCodexx will commercialize Osteolabs' osteoporosis test in Germany, while BioGen Medical will do the same in Turkey.
The researchers will use Agilent's Fourier-transform infrared spectroscopy technology to monitor infants and determine those at highest risk of developing atopic eczema.
The test, which is in development using perspiration as a sample, has shown promising performance in a preliminary study.
